Generating Knowledge that Cures with precision
SIREN: 931797674
HEADQUARTERS
149 Avenue du Maine
75014 Paris, France, EU
LABORATORIES
Spartners – Servier/Biolabs Innovation Labs
22 Route 128
91190 Gif-sur-Yvette, France, EU
Acknowledgements:
For ages, the complexity of the central nervous system (CNS) has blocked effective treatment of neurological conditions—our platform unlocks a new paradigm in brain health
Despite significant scientific progress, effective clinical therapies for diseases such as Alzheimer’s, Parkinson’s, and glioblastoma remain elusive due to a range of persistent challenges.
BIOLOGICAL COMPLEXITY
CNS architecture and components inter-relations.
Pathologies and patient specificities.
TECHNICAL LIMITATIONS
Limited pedictive validity of current disease models.
Lack of preclinical relevant longitudinal data.
RETURN ON INVESTMENT
Long timelines and high costs of discovery/development.
High clinical failure of promising therapies.
OWL aims to lead the frontier of brain biotech— Setting the standard for innovation, precision, and impact in neurotherapeutics through an exclusive platform with a realistic human CNS in vitro model at its core.
We bring a unique solution to discover and develop new advanced therapeutic modalities and in vivo delivery strategies for the brain by combining unique clinically-relevant longitudinal multimodal data, issued from proprietary automated in vitro human CNS models, and Artificial Intelligence.
Shaping the future of brain health, through responsible innovation and strategic collaboration
Owl’s team is deeply committed to upholding the highest standards of ethics and respect for life in our pursuit. We actively engage with international associations, regularly consult with key opinion leaders across science, technology, medicine, and society, and maintain close dialogue with patient communities. We strive to anticipate and mitigate any potential negative impacts of our technologies, carefully weighing human benefit against risk in every strategic decision. We welcome partnerships and collaborations with organisations, institutions, or companies around the world that share our values and mission.
Generating Knowledge that Cures with precision
For ages, the complexity of the central nervous system (CNS) has blocked effective treatment of neurological conditions—our platform unlocks a new paradigm in brain health
Despite significant scientific progress, effective clinical therapies for diseases such as Alzheimer’s, Parkinson’s, and glioblastoma remain elusive due to a range of persistent challenges.
BIOLOGICAL COMPLEXITY
CNS architecture and components inter-relations.
Pathologies and patient specificities.
TECHNICAL LIMITATIONS
Limited pedictive validity of current disease models.
Lack of preclinical relevant longitudinal data.
DISCOVERY/ DEVELOPMENT
Long timelines and high costs of discovery/development.
High clinical failure of promising therapies.
OWL aims to lead the frontier of brain biotech— Setting the standard for innovation, precision, and impact in neurotherapeutics through an exclusive platform with a realistic human CNS in vitro model at its core.
Owl Lifesciences brings a solution to discover and develop new advanced therapeutic modalities and in vivo delivery strategies for the brain by combining unique clinically-relevant longitudinal multimodal data, issued from proprietary automated in vitro human CNS models, and Artificial Intelligence.
Shaping the future of brain health, through responsible innovation and strategic collaboration
Owl’s team is deeply committed to upholding the highest standards of ethics and respect for life in our pursuit. We actively engage with international associations, regularly consult with key opinion leaders across science, technology, medicine, and society, and maintain close dialogue with patient communities. We strive to anticipate and mitigate any potential negative impacts of our technologies, carefully weighing human benefit against risk in every strategic decision. We welcome partnerships and collaborations with organisations, institutions, or companies around the world that share our values and mission.